Compile Data Set for Download or QSAR
maximum 50k data
Found 2387 with Last Name = 'dodd' and Initial = 'jh'
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Bristol-Myers Squibb

LigandPNGBDBM16318(3-({5-cyano-6-[(2,2-dimethylpropyl)(methyl)amino]-...)
Affinity DataKi:  0.0470nM ΔG°:  -58.4kJ/molepH: 7.4 T: 2°CAssay Description:The kinase activity was determined by quantitation of the amount of radioactive phosphate transferred to myelin basic protein (MBP) with or without i...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Bristol-Myers Squibb

LigandPNGBDBM16319(3-({2-amino-5-cyano-6-[(2,2-dimethylpropyl)(methyl...)
Affinity DataKi:  0.0500nM ΔG°:  -58.2kJ/molepH: 7.4 T: 2°CAssay Description:The kinase activity was determined by quantitation of the amount of radioactive phosphate transferred to myelin basic protein (MBP) with or without i...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160158(US9040663, 4)
Affinity DataKi:  0.0550nM ΔG°:  -60.9kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160159(US9040663, 5)
Affinity DataKi:  0.0550nM ΔG°:  -60.9kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Bristol-Myers Squibb

LigandPNGBDBM16317(3-({5-cyano-6-[(2,2-dimethylpropyl)(methyl)amino]-...)
Affinity DataKi:  0.0570nM ΔG°:  -57.9kJ/molepH: 7.4 T: 2°CAssay Description:The kinase activity was determined by quantitation of the amount of radioactive phosphate transferred to myelin basic protein (MBP) with or without i...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Bristol-Myers Squibb

LigandPNGBDBM16329(3-({2-amino-5-cyano-6-[(1-methylethyl)amino]pyrimi...)
Affinity DataKi:  0.0570nM ΔG°:  -57.9kJ/molepH: 7.4 T: 2°CAssay Description:The kinase activity was determined by quantitation of the amount of radioactive phosphate transferred to myelin basic protein (MBP) with or without i...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160174(US9040663, 20)
Affinity DataKi:  0.0600nM ΔG°:  -60.7kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160157(US9040663, 3)
Affinity DataKi:  0.0800nM ΔG°:  -59.9kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160175(US9040663, 21)
Affinity DataKi:  0.0850nM ΔG°:  -59.8kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160169(US9040663, 15)
Affinity DataKi:  0.145nM ΔG°:  -58.4kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160170(US9040663, 16)
Affinity DataKi:  0.150nM ΔG°:  -58.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Bristol-Myers Squibb

LigandPNGBDBM16320(3-({5-cyano-6-[(2,2-dimethylpropyl)(methyl)amino]p...)
Affinity DataKi:  0.150nM ΔG°:  -55.5kJ/molepH: 7.4 T: 2°CAssay Description:The kinase activity was determined by quantitation of the amount of radioactive phosphate transferred to myelin basic protein (MBP) with or without i...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Bristol-Myers Squibb

LigandPNGBDBM16330(3-{[2-amino-5-cyano-6-(cyclopentylamino)pyrimidin-...)
Affinity DataKi:  0.160nM ΔG°:  -55.3kJ/molepH: 7.4 T: 2°CAssay Description:The kinase activity was determined by quantitation of the amount of radioactive phosphate transferred to myelin basic protein (MBP) with or without i...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Bristol-Myers Squibb

LigandPNGBDBM50376226(CHEMBL259922)
Affinity DataKi:  0.200nMAssay Description:Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160159(US9040663, 5)
Affinity DataKi:  0.200nM ΔG°:  -57.6kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Bristol-Myers Squibb

LigandPNGBDBM50376226(CHEMBL259922)
Affinity DataKi:  0.200nMAssay Description:Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160165(US9040663, 11)
Affinity DataKi:  0.25nM ΔG°:  -57.0kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160208(US9040663, 54)
Affinity DataKi:  0.25nM ΔG°:  -57.0kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160170(US9040663, 16)
Affinity DataKi:  0.25nM ΔG°:  -57.0kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160180(US9040663, 26)
Affinity DataKi:  0.300nM ΔG°:  -56.5kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160201(US9040663, 47)
Affinity DataKi:  0.300nM ΔG°:  -56.5kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160157(US9040663, 3)
Affinity DataKi:  0.300nM ΔG°:  -56.5kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucocorticoid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50348414(CHEMBL1800984)
Affinity DataKi:  0.300nMAssay Description:Displacement of GS-red from GRapha by fluorescence polarization assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160217(US9040663, 63)
Affinity DataKi:  0.350nM ΔG°:  -56.1kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160173(US9040663, 19)
Affinity DataKi:  0.400nM ΔG°:  -55.8kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM135736(US10179804, Example 121 | US10632171, Peptide No. ...)
Affinity DataKi:  0.400nMpH: 7.5Assay Description:A competitive inhibition binding assay is performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMC4-R, hMC3-R, o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM135752(US10179804, Example 137 | US10632171, Peptide No. ...)
Affinity DataKi:  0.400nMpH: 7.5Assay Description:A competitive inhibition binding assay is performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMC4-R, hMC3-R, o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM135736(US10179804, Example 121 | US10632171, Peptide No. ...)
Affinity DataKi:  0.400nMAssay Description:A competitive inhibition binding assay is performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMC4-R, hMC3-R, o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM135752(US10179804, Example 137 | US10632171, Peptide No. ...)
Affinity DataKi:  0.400nMAssay Description:A competitive inhibition binding assay is performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMC4-R, hMC3-R, o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM135752(US10179804, Example 137 | US10632171, Peptide No. ...)
Affinity DataKi:  0.400nM ΔG°:  -55.8kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay is performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMC4-R, hMC3-R, o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM135736(US10179804, Example 121 | US10632171, Peptide No. ...)
Affinity DataKi:  0.400nMAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucocorticoid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50348407(CHEMBL1801006)
Affinity DataKi:  0.400nMAssay Description:Displacement of GS-red from GRapha by fluorescence polarization assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucocorticoid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50348412(CHEMBL1800982)
Affinity DataKi:  0.400nMAssay Description:Displacement of GS-red from GRapha by fluorescence polarization assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM135736(US10179804, Example 121 | US10632171, Peptide No. ...)
Affinity DataKi:  0.400nM ΔG°:  -55.8kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay is performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMC4-R, hMC3-R, o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM135752(US10179804, Example 137 | US10632171, Peptide No. ...)
Affinity DataKi:  0.400nMAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Bristol-Myers Squibb

LigandPNGBDBM16325(3-({5-cyano-6-[(1-methylethyl)amino]pyrimidin-4-yl...)
Affinity DataKi:  0.410nM ΔG°:  -53.0kJ/molepH: 7.4 T: 2°CAssay Description:The kinase activity was determined by quantitation of the amount of radioactive phosphate transferred to myelin basic protein (MBP) with or without i...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
Bristol-Myers Squibb

LigandPNGBDBM16324(3-{[5-cyano-6-(cyclopentylamino)pyrimidin-4-yl]ami...)
Affinity DataKi:  0.420nM ΔG°:  -53.0kJ/molepH: 7.4 T: 2°CAssay Description:The kinase activity was determined by quantitation of the amount of radioactive phosphate transferred to myelin basic protein (MBP) with or without i...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160178(US9040663, 24)
Affinity DataKi:  0.450nM ΔG°:  -55.5kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucocorticoid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50440220(CHEMBL2426624)
Affinity DataKi:  0.480nMAssay Description:Binding affinity to glucocorticoid receptor (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucocorticoid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50440220(CHEMBL2426624)
Affinity DataKi:  0.480nMAssay Description:Binding affinity to glucocorticoid receptor (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160172(US9040663, 18)
Affinity DataKi:  0.5nM ΔG°:  -55.2kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160183(US9040663, 29)
Affinity DataKi:  0.5nM ΔG°:  -55.2kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160165(US9040663, 11)
Affinity DataKi:  0.5nM ΔG°:  -55.2kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160158(US9040663, 4)
Affinity DataKi:  0.5nM ΔG°:  -55.2kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160253(US9040663, 99)
Affinity DataKi:  0.5nM ΔG°:  -55.2kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlucocorticoid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50440105(CHEMBL2426114)
Affinity DataKi:  0.530nMAssay Description:Binding affinity to glucocorticoid receptor (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160167(US9040663, 13)
Affinity DataKi:  0.600nM ΔG°:  -54.8kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM135690(US10179804, Example 75 | US10632171, Peptide No. 7...)
Affinity DataKi:  0.600nMpH: 7.5Assay Description:A competitive inhibition binding assay is performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMC4-R, hMC3-R, o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM135690(US10179804, Example 75 | US10632171, Peptide No. 7...)
Affinity DataKi:  0.600nMAssay Description:A competitive inhibition binding assay is performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMC4-R, hMC3-R, o...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelanocortin receptor 4(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM160206(US9040663, 52)
Affinity DataKi:  0.600nM ΔG°:  -54.8kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed for exemplified peptides according to the invention using membrane homogenates prepared from HEK...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 2387 total ) | Next | Last >>
Jump to: